Literature DB >> 16330966

Breast cancer survivors' intentions of managing lymphedema.

Mei R Fu1.   

Abstract

The purpose of this study was to describe the experience of managing lymphedema in breast cancer survivors. A descriptive phenomenological method was used as a guide for developing a bracket, gathering data, and analyzing data. A cross-sectional design with a purposive sampling technique was employed. During the 3 private, semi-structured, audio-recorded interviews with each woman, 12 breast cancer survivors described how they managed lymphedema in their daily lives. A taxonomy of 3 levels was created to describe the essential structures of the experience from general, to mediating, to specific: revelatory intention, cluster intention, and unit intention. The study revealed that the women's major intentions of managing lymphedema were to keep in mind the consequences, prevent lymphedema from getting worse, get ready to live with lymphedema, and integrate the care of lymphedema into daily life. Findings of the study provided an insightful alternative to the compliance approach to lymphedema management. Instead of merely evaluating breast cancer survivors' degree of compliance with treatment, it is suggested that researchers and practitioners should also assess the impact of the presence or absence of the women's intentions on lymphedema management.

Entities:  

Mesh:

Year:  2005        PMID: 16330966     DOI: 10.1097/00002820-200511000-00007

Source DB:  PubMed          Journal:  Cancer Nurs        ISSN: 0162-220X            Impact factor:   2.592


  15 in total

1.  Voices from the shadows: living with lymphedema.

Authors:  Sheila H Ridner; Candace M Bonner; Jie Deng; Vaughn G Sinclair
Journal:  Cancer Nurs       Date:  2012 Jan-Feb       Impact factor: 2.592

Review 2.  Management of secondary lymphedema related to breast cancer.

Authors:  Oren Cheifetz; Louise Haley
Journal:  Can Fam Physician       Date:  2010-12       Impact factor: 3.275

3.  Randomised controlled trial to determine the benefit of daily home-based exercise in addition to self-care in the management of breast cancer-related lymphoedema: a feasibility study.

Authors:  Eunice Jeffs; Theresa Wiseman
Journal:  Support Care Cancer       Date:  2012-10-17       Impact factor: 3.603

4.  Body Image of Women with Breast Cancer After Mastectomy: A Qualitative Research.

Authors:  Sema Koçan; Ayla Gürsoy
Journal:  J Breast Health       Date:  2016-10-01

5.  How people construct their experience of living with secondary lymphoedema in the context of their everyday lives in Australia.

Authors:  Judith A Meiklejohn; Kristiann C Heesch; Monika Janda; Sandra C Hayes
Journal:  Support Care Cancer       Date:  2012-07-18       Impact factor: 3.603

6.  Problems in transition and quality of care: perspectives of breast cancer survivors.

Authors:  Aimee Kendall Roundtree; Sharon H Giordano; Andrea Price; Maria E Suarez-Almazor
Journal:  Support Care Cancer       Date:  2010-12-09       Impact factor: 3.603

7.  mHealth self-care interventions: managing symptoms following breast cancer treatment.

Authors:  Mei R Fu; Deborah Axelrod; Amber A Guth; Kavita Rampertaap; Nardin El-Shammaa; Karen Hiotis; Joan Scagliola; Gary Yu; Yao Wang
Journal:  Mhealth       Date:  2016-07-22

8.  Breast cancer-related lymphedema patient and healthcare professional experiences in lymphedema self-management: a qualitative study.

Authors:  Huihui Zhao; Yanni Wu; Chunlan Zhou; Wenji Li; Xiaojin Li; Liling Chen
Journal:  Support Care Cancer       Date:  2021-07-05       Impact factor: 3.603

9.  Breast cancer survivors' experiences of lymphedema-related symptoms.

Authors:  Mei Rosemary Fu; Mary Rosedale
Journal:  J Pain Symptom Manage       Date:  2009-12       Impact factor: 3.612

10.  Breast cancer survivors' perspectives of critical lymphedema self-care support needs.

Authors:  Sheila H Ridner; Bethany A Rhoten; M Elise Radina; Melissa Adair; Sydney Bush-Foster; Vaughn Sinclair
Journal:  Support Care Cancer       Date:  2016-01-26       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.